Graviti Pharmaceuticals is a research-focused formulation firm established in Hyderabad, India to produce complex generics of the highest quality. Our efforts are specially focused on modified-release, bio and stability sensitive molecules, as well as novel drug delivery platforms.
We consider superior manufacturing to be truly critical for success. We strive to meet and exceed regulatory standards to deliver products that are consistently of higher quality. We build lasting partnerships on a foundation of reliability, integrity, transparency and responsiveness.
We put ‘value’ at the heart of everything we do, to ensure that we always adapt, execute and deliver products that are of the highest quality and the most reliable.
We firmly believe in establishing strong partnerships with our customers, partners, employees and the community, through managed growth, innovation, competitiveness, trust and concern for the environment.
We will develop and manufacture pharmaceuticals of the highest quality. We will lower the cost of healthcare for our customers through smart investments in R&D and efficient processes.
About Our Group
Graviti Pharmaceuticals is a group concern of the prestigious Yashoda Group which was established in 1978 and has been an epitome of unmatched quality and innovation ever since.
The group has a diverse business portfolio with business operations spanning major sectors such as healthcare service, pharmaceuticals, IT & ITES, chemical engineering, special materials and education, and has a cumulative workforce of about 6000 employees.
The Group, given its experience of over two decades in healthcare, has identified the need to develop a pharmaceutical generics formulation firm to produce high-quality, low-cost drugs for the domestic and international markets.